Quality of Life in Neuromuscular Disease (QoLNMD)

September 22, 2016 updated by: CHU de Reims

Development of a New Scale of Quality of Life, Specific of Neuro Muscular Diseases and More Specifically of Steinert Disease, by the Rasch Model Methods.

A Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies. The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers MNMs. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed. The transcript provided 2424 CIF categories. The results helped to identify and quantify aspects of life that are altered by NMDs between patients. A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were thern passed by 159 patients enrolled in eight reference centers MNMs. The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire. The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRT measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system. A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. 156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties and met IRT assumptions. The IRT model calibration was then performed successfully on 315 patients. The French version of the QoL-NMD showed adequate psychometric properties and can be used in rehabilitation services. A conversion table enables easy transformation of sum scores into IRT-calibrated measures. Minimum detectable change tables help interpreting score change.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies.

The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers NMDs. To ensure that the performance in terms of severity would be adequate, three focus groups were formed: (1) Patients capable of walking. (2) Patients in wheelchairs. (3) Patients in wheelchairs and requiring continue ventilatory support. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed according to the framework of the International Classification of Functioning, Disability and Health (ICF).

A total of 41 patients divided into five discussion groups were interviewed. The transcript provided 2424 ICF categories. References to percentages of different categories ICF were calculated and graphed.

The results helped to identify and quantify aspects of life that are altered by MNMs between patients. This qualitative work was the first phase of the ambitious project to develop a new specific questionnaire for NMDs HRQoL.

Build a questionnaire for assessing the quality of health-related life (HRQoL) in patients with NMD using item response theory (IRT).

A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were passed by 159 patients enrolled in eight reference centers MNMs. The exploratory analysis included statistical methods derived from both the TRI and classical test theory.

The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire.

This study has allowed the development of a new HRQL questionnaire specifically designed for patients with MNM. The QoLNMD is short enough to be used in clinical practice (26 items).

The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRR measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system.

A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. Confirmatory psychometric analyses were performed on the new sample while the Items Response Theory (IRT) model calibration was performed on all patients ever recruited using the Partial Credit Model (Rasch).

156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties (internal consistency: repeatability ; scalability) and met IRT assumptions. The IRT model calibration was performed successfully on 315 patients. Minimum detectable change estimates are distribution based and should be verified by external meaningful anchors.

Study Type

Observational

Enrollment (Actual)

159

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Reims, France, 51092
        • CHU de Reims

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

French Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form.

Description

Inclusion Criteria:

  • Patient with neuromuscular disease

Exclusion Criteria:

  • <18 yo

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Neuro Muscular disease patients
French Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self reported form of items measuring the Quality of Life
Time Frame: 0 month
The Quality of Life questionnaire used is QoLNMD
0 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self reported form of items measuring the Quality of Life
Time Frame: 6 months
The Quality of Life questionnaire used is QoLNMD
6 months
Self reported form of items measuring the Quality of Life
Time Frame: 1 year
The Quality of Life questionnaire used is QoLNMD
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2006

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

August 18, 2016

First Submitted That Met QC Criteria

September 6, 2016

First Posted (Estimate)

September 12, 2016

Study Record Updates

Last Update Posted (Estimate)

September 23, 2016

Last Update Submitted That Met QC Criteria

September 22, 2016

Last Verified

September 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Form administrations

3
Subscribe